3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
13
Phase 1/2
10
Phase EARLY_PHASE1
2
Phase 2
2
Status
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other solid neoplasm
2
Conditions
Mesothelioma, Malignant
120
Mesothelioma
70
Solid Tumor
46
Solid Tumors
33
Retinoblastoma
27
Solitary Fibrous Tumor, Pleural
20
Sarcoma
17
Advanced Solid Tumor
16
Advanced Solid Tumors
15
Lung Neoplasms
13
Small Cell Lung Carcinoma
12
Carcinoma, Non-Small-Cell Lung
11
Osteosarcoma
9
Neuroblastoma
8
Ovarian Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Solid Tumor, Adult
6
Colorectal Neoplasms
6
Cholangiocarcinoma
6
Central Nervous System Neoplasms
6
Carcinoma, Renal Cell
6
Uterine Cervical Neoplasms
5
Thyroid Neoplasms
5
Stomach Neoplasms
5
Neoplasms
5
Melanoma
5
Medulloblastoma
5
Chondrosarcoma
5
Carcinoma, Hepatocellular
5
Breast Neoplasms
5
Interventions
nabiximols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Advanced Malignant Solid Tumor
×
Other solid neoplasm
×
Clear all
NCT07541001
2026-04-23
China Phase II
Intra-IMMUSG Pte Ltd
Phase 2
Active not recruiting
60 enrolled
NCT07459920
2026-03-10
CAPTURE
National Cancer Institute, Naples
Phase 2
Not yet recruiting
156 enrolled